For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260204:nRSD7612Ra&default-theme=true
RNS Number : 7612R Canadian Imperial Bank of Commerce 04 February 2026
Publication of Prospectus Supplement
Not for release, publication or distribution, directly or indirectly, in or
into the United States.
The following prospectus supplement has been approved as supplementary
admission particulars in respect of Notes to be admitted to trading on the
International Securities Market of the London Stock Exchange plc:
Fourth Prospectus Supplement dated 4 February 2026 to the Structured Notes
Base Prospectus relating to the Structured Note Programme of Canadian Imperial
Bank of Commerce ("Fourth Prospectus Supplement").
The Fourth Prospectus Supplement will shortly be available for inspection on
Canadian Imperial Bank of Commerce's website at Structured Note Issuance
Programme | CIBC
(https://www.cibc.com/en/about-cibc/investor-relations/debt-information/structured-note-issuance-programme.html)
.
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the base prospectus dated 12 May
2025 as supplemented by the first prospectus supplement dated 30 May 2025, the
second prospectus supplement dated 29 August 2025, the third prospectus
supplement dated 4 December 2025 and the Fourth Prospectus Supplement
(together, the "Prospectus"), may be addressed to and/or targeted at persons
who are residents of particular countries (specified in the Prospectus) only
and is not intended for use and should not be relied upon by any person
outside these countries and/or to whom the offer contained in the prospectus
is not addressed. Prior to relying on the information contained in the
Prospectus you must ascertain from the Prospectus whether or not you are part
of the intended addressees of the information contained therein.
The Notes have not been and will not be registered under the United States
Securities Act of 1933, as amended (the "Securities Act") or the securities
laws of any state of the United States and are subject to US tax law
requirements. Subject to certain exceptions, the Notes may not be offered,
sold or delivered, directly or indirectly, in or into the US or to or for the
account or benefit of a "US person" (as defined in Regulation S under the
Securities Act). No public offering of the Notes is being made in the
US. This announcement does not constitute an offer to sell or a solicitation
to buy securities in the United States or in any other jurisdiction where such
offer or solicitation would be unlawful. Your right to access this service is
conditional upon complying with the above requirement.
To view the full document, please paste the following URLs into the address
bar of your browser.
Fourth Prospectus Supplement dated 4 February 2025
http://www.rns-pdf.londonstockexchange.com/rns/7612R_1-2026-2-4.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/7612R_1-2026-2-4.pdf)
For further information, please contact:
Canadian Imperial Bank of Commerce
81 Bay St.
Canada Square
Toronto, Ontario
Canada M5J 0E7
Attn: Senior Vice-President, Funding and Liquidity
Tel: +1-416-581-7343
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END PSPUPURPPUPQGQC
Copyright 2019 Regulatory News Service, all rights reserved